Greg Yap is a partner at Menlo Ventures investing in life science and healthcare. He previously held roles at Illumina Ventures and several operating companies.
At firms with a similar stage, sector and check size.
One email when Greg's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckGreg Yap is a partner at Menlo Ventures investing in life science and healthcare. He previously held roles at Illumina Ventures and several operating companies.
Greg Yap invests through Menlo Ventures, which writes checks of $1M to $30M+ at seed, series a, series b.
A warm intro from a founder Menlo Ventures backed works best.
led a global market-leading cancer diagnostic assay business at Roche Diagnostics/Ventana; CEO and co-founder at PyrAmes; CEO and co-founder at BlueLight Therapeutics (originally Biodesy); entrepreneur-in-residence at Illumina Ventures; healthcare entrepreneur-in-residence at GE; Roche Diagnostics/Ventana; CEO and co-founder at BlueLight Therapeutics.
Last updated 2026-10-15. Is this you? Ask for a correction.